Currently, BPC-157 is not classified as a controlled substance, and standard drug panels (such as those screening for narcotics, cannabinoids, or anabolic steroids) do not typically test for peptides like BPC-157
Later studies found similar patterns in Alzheimer's disease, Parkinson's disease, and COVID-19
The ability to precisely calculate AHK-Cu dosage allows for this controlled, methodical adjustment
While no evidence directly links BPC-157 to cancer development or progression, individuals with cancer history, undiagnosed masses, or strong family history of aggressive cancers should exercise caution
The same study showed that Dihexa potentiates HGF-stimulated c-Met phosphorylation and downstream signaling at concentrations consistent with high-affinity binding
R.YadavS.DhaliwalJ.YadavM.KondepudiK